Ondansetron Tablet, Orally Disintegrating
Product Images NDC 43063-273

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-273). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063273)

Ondansetron ODT USP 8 mg orally disintegrating tablets, 4 count label from PD-Rx Pharmaceuticals, Inc. The label shows the NDC 43063-273-04, along with reorder number, lot number SAMPLE, and expiration date 01/2050. It includes a warning to keep out of reach of children and directs to see the package insert for dosage and storage. Label also includes barcode and packaging location Oklahoma City, OK.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure diagram of the active ingredient ondansetron, showing its molecular framework with rings and functional groups clearly outlined.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of ondansetron hydrochloride dihydrate, showing the indole-like ring fused to a cyclohexanone and a methyl-substituted imidazole ring, with the hydrochloride and two water molecules indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.